Log in to save to my catalogue

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51b2a4e16a0b435cabee2477f3975980

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

About this item

Full title

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-09, Vol.8 (1), p.451-8, Article 451

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

T-cell-based immunotherapies are promising treatments for cancer patients. Although durable responses can be achieved in some patients, many patients fail to respond to these therapies, underscoring the need for improvement with combination therapies. From a screen of 850 bioactive compounds, we identify HSP90 inhibitors as candidates for combinati...

Alternative Titles

Full title

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_51b2a4e16a0b435cabee2477f3975980

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51b2a4e16a0b435cabee2477f3975980

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-00449-z

How to access this item